QSP and Bayesian Inference

Understand how systems pharmacology and Bayesian approaches extend pharmacometrics into systems-level modeling and probabilistic reasoning.
Tip

What you’ll build today: a high-level understanding of how QSP and Bayesian inference expand pharmacometrics into systems modeling and probabilistic thinking.

Learning Objectives

By the end of this lesson, you will be able to:

  • Define Quantitative Systems Pharmacology (QSP)
  • Understand the role of Bayesian inference in PMx
  • Distinguish these approaches from traditional PK/PD
  • Recognize when these frameworks are useful

Key Ideas

So far, models have focused on:

  • PK (drug movement)
  • PD (drug effect)
  • exposure–response

Now we extend further into:

systems-level modeling and probabilistic reasoning


Why This Lesson Matters

Some questions cannot be answered by standard PK/PD models:

  • How do multiple biological pathways interact?
  • How do we incorporate prior knowledge?
  • How do we reason under uncertainty?

This is where QSP and Bayesian approaches come in.


Two Different Ways of Extending Pharmacometrics

This lesson introduces two different dimensions of modeling.

QSP extends:

What we model

Bayesian inference extends:

How we learn from data

These are complementary ideas.

A QSP model can even be estimated using Bayesian methods.


Quantitative Systems Pharmacology (QSP)

QSP models aim to represent:

biological systems and their interactions

They combine:

  • physiology
  • molecular biology
  • pharmacology

Worked Example: Systems Thinking

flowchart LR

Drug["Drug"]

Target["Target"]

Pathway["Signaling Pathway"]

Bio["Biomarker"]

Effect["Clinical Effect"]

Drug --> Target
Target --> Pathway
Pathway --> Bio
Bio --> Effect

Pathway -. feedback .-> Target

Instead of modeling only:

Concentration → Effect

QSP attempts to represent:

  • intermediate biology
  • interacting pathways
  • feedback mechanisms

This allows models to explain how responses emerge.


Insight

QSP moves from describing behavior toward representing biological mechanisms.

Note

QSP models are often complex but provide deeper biological insight.


Bayesian Inference

Bayesian approaches focus on:

updating knowledge using data

Core idea:

\[ P(\theta \mid y) \propto P(y \mid \theta) P(\theta) \]

Where:

  • \(P(\theta)\) = prior knowledge
  • \(P(y\mid\theta)\) = likelihood (information from data)
  • \(P(\theta\mid y)\) = posterior (updated knowledge)

Where:

  • Prior = what we know before
  • Likelihood = data information
  • Posterior = updated knowledge

Interpretation

Bayesian methods allow you to:

  • incorporate prior knowledge
  • quantify uncertainty
  • update beliefs as new data arrive

A Bayesian Mental Model

Bayesian inference combines:

Previous knowledge
+
New data
=
Updated understanding

This process repeats as new information becomes available.


Expanding the Idea

Bayesian approaches are useful for:

  • small datasets
  • adaptive trials
  • integrating multiple data sources

Insight

Bayesian inference treats parameters as uncertain quantities, not fixed values.

Note

This aligns naturally with decision-making under uncertainty.


Why This Matters for Decisions

These approaches support:

  • complex biological understanding (QSP)
  • uncertainty-aware decisions (Bayesian)

Strategies

  • Use QSP when biology is central
  • Use Bayesian methods when prior knowledge matters
  • Balance complexity with interpretability

Common Mistakes

  • Overcomplicating models unnecessarily
  • Misinterpreting Bayesian outputs
  • Ignoring uncertainty

Practice Problems

  1. What is QSP?
  2. What does Bayesian inference do?
  3. When are these approaches useful?

  1. Systems-level pharmacology modeling
  2. Updates knowledge using data and priors
  3. When complexity or uncertainty is high

Summary

QSP and Bayesian approaches:

  • extend PMx into systems and uncertainty
  • support complex modeling and decision-making

  • QSP = systems biology
  • Bayesian = probabilistic reasoning
  • Use when standard models are insufficient
  • Always balance complexity and clarity